Study of Radiological Imaging and Outcomes in Men with Prostate Cancer or High Risk for Prostate Cancer

What this Trial Is About

This research aims to improve understanding of prostate cancer by collecting data about its radiological and clinical progression. Researchers are studying imaging-based markers that might help profile prostate cancer, which could lead to better diagnosis and treatment decisions. The study focuses on men aged 18 and older who are diagnosed with or suspected of having prostate cancer. Participants include men at increased risk for prostate cancer or those with prostate cancer or suspicious lesions. The study involves gathering imaging and clinical data over at least five years, including multiparametric MRI scans and medical history from visits to the National Cancer Institute or external providers. This data is analyzed to identify imaging markers related to prostate cancer. During the study, participants medical records and imaging results will be reviewed and collected for analysis. Researchers measure associations between imaging features and clinical or pathological factors over a 10-year period. The study does not involve experimental treatments, and participant involvement consists mainly of data collection and monitoring over time.

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer